Trial intelligence / Profile preview

Montelukast in Atopic Syndrome

NCT00559546Phase 4Completed

Sponsor
University of Helsinki
Start
Mar 2007
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of montelukast in seasonal allergic rhinitis (SAR), allergic conjunctivitis (AC), atopic dermatitis (AD), asthma, sponsored by University of Helsinki. Started Mar 2007; status: completed.

02

Drugs

montelukast
03

Conditions

seasonal allergic rhinitis (SAR)allergic conjunctivitis (AC)atopic dermatitis (AD)asthma

Beyond the preview

Go deeper on NCT00559546.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00559546.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call